Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.28−0.05 (-3.76%)
Close on Nov 13, 2026Market cap $217.02MP/E –Yield –
Cabaletta Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cabaletta Bio's enterprise value was $166.83M on Apr 30, 2026, against -$66.26M a year earlier. Over the last 5 years it ranged from -$96.98M to $852.95M, with a median of $136.69M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Apr 30, 2026 | $166.83M | +227.8% |
| 2025 | Dec 31, 2025 | $50.89M | – |
| 2024 | Dec 31, 2024 | -$72.12M | -109.2% |
| 2023 | Dec 29, 2023 | $781.29M | +328.1% |
| 2022 | Dec 30, 2022 | $182.48M | – |
| 2021 | Dec 31, 2021 | -$14.16M | -107.8% |
| 2020 | Dec 31, 2020 | $182.14M | – |
| 2019 | Dec 31, 2019 | -$17.28M | – |
See a number that looks wrong?